Brief: Calidi Biotherapeutics Announces Pricing Of $6.1 Million Public Offering
16/04/2024 13:39
April 16 (Reuters) - Calidi Biotherapeutics Inc
CLDI.A :
* CALIDI BIOTHERAPEUTICS, INC. ANNOUNCES PRICING OF $6.1
MILLION
PUBLIC OFFERING
* CALIDI BIOTHERAPEUTICS INC: COMBINED PRICE OF $0.40 PER
SHARE
AND COMMON WARRANTS FOR AGGREGATE GROSS PROCEEDS OF
APPROXIMATELY $6.1 MILLION
Source text for Eikon: ID:nBw2Y7dgKa
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma